Venetoclax plus Rituximab New Chemotherapy-Free Option for Chronic Lymphocytic Leukemia.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 23
- By:
- Publication type:
- Article
Works matching IS 21644403 AND DT 2018 AND VI 8 AND IP 3
Results: 19
1
2
Survey Highlights Need for Improved Patient-Provider Communication and Symptom Management.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 22
- By:
- Publication type:
- Article
3
A New Combination as First-Line Regimen in Advanced Hodgkin Lymphoma?
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 26
- By:
- Publication type:
- Article
4
Recent FDA Approvals for Acute Lymphoblastic Leukemia a "Watershed" Moment.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 24
- By:
- Publication type:
- Article
5
Treatment Considerations for Relapsed or Refractory Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 28
- By:
- Publication type:
- Article
6
Select Clinical Trials Currently Enrolling Patients with Lymphoma.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 31
- Publication type:
- Article
7
Immunotherapy Combination Shows Durable Responses in Mismatch Repair-Deficient Metastatic Colorectal Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 19
- By:
- Publication type:
- Article
8
Imfinzi First Treatment Approved to Reduce Disease Progression in Unresectable Stage III NSCLC After Chemoradiation.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 17
- Publication type:
- Article
9
Erleada First Therapy Approved for Patients with Nonmetastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 17
- Publication type:
- Article
10
Zytiga Receives New Indication, with Prednisone, for Metastatic, High-Risk Castration-Sensitive Prostate Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 16
- Publication type:
- Article
11
Lutathera First Radioactive Drug Approved for Adults with Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 16
- Publication type:
- Article
12
Gilotrif Receives New Indication as First-Line Treatment for Metastatic NSCLC with Nonresistant EGFR Mutations.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 15
- Publication type:
- Article
13
Lynparza First Treatment Approved for Patients with Germline BRCA-Positive Metastatic Breast Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 15
- Publication type:
- Article
14
Direct Oral Anticoagulants: New Standard of Care for VTE in Patients with Cancer?
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 12
- By:
- Publication type:
- Article
15
Using Goals-of-Care Videos Can Revolutionize End-of-Life Decisions.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
16
Utilization of Palliative Care "Dismal" for Patients with Hematologic Malignancies.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 8
- By:
- Publication type:
- Article
17
Regorafenib Dose-Escalation Strategy Potentially a New Standard in Metastatic Colorectal Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 1
- By:
- Publication type:
- Article
18
Managing Fatigue in Patients with Advanced Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 1
- By:
- Publication type:
- Article
19
Begin End-of-Life Conversations When Diagnosing Metastatic Disease.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 3, p. 1
- By:
- Publication type:
- Article